A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
Titel:
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
Auteur:
Pereira, Maria J. Lundkvist, Per Kamble, Prasad G. Lau, Joey Martins, Julian G. Sjöström, C. David Schnecke, Volker Walentinsson, Anna Johnsson, Eva Eriksson, Jan W.